From: CAR T cells in solid tumors: challenges and opportunities
Cancer | Antigen |
---|---|
Colorectal | NKG2D [54], EP-CAM [55], HER2 [56], GUCY2C [57], TAG-72 [58], CD46 [58] |
Liver | |
Gastric | Mesothelin [62], ANTXR1 [63], MUC3A [63], Trop2 [64], Claudin18.2 [66], NKG2D [28], HER2 [65, 66], FR-α [67] |
Pancreatic | MUC1 [68], Mesothelin [69], αvβ6 [70], CEA [71], PSCA [71], FAP [71], CD47 [72], HER2 [73], NKG2D [74] |
Renal | CAIX [75] |
Melanoma | |
Cervix | |
Neuroblastoma | |
Glioblastoma | EGFRvIII [87], HER2 [88], B7-H3 [89], NKG2D [90], CAIX [91], αvβ3, IL13Rα2 [92] |
Ovarian | Mesothelin [62, 93], αvβ6 [94], B7-H3 [95], CD47 [72], NKG2D [96] |
Prostate | |
Lung | |
Head and neck | HER2 [105] |